| NIPRIDE |
017546 |
001 |
NDA |
SODIUM NITROPRUSSIDE |
INJECTABLE;INJECTION |
50MG/VIAL |
No
|
No
|
1974/05/10
|
Approved Prior to Jan 1, 1982
|
ROCHE |
Discontinued |
| NIPRIDE RTU IN SODIUM CHLORIDE 0.9% |
209387 |
001 |
NDA |
SODIUM NITROPRUSSIDE |
SOLUTION;INTRAVENOUS |
50MG/100ML (0.5MG/ML) |
Yes
|
Yes
|
2017/03/08
|
2017/03/08
|
EXELA PHARMA |
Prescription |
| NIPRIDE RTU IN SODIUM CHLORIDE 0.9% |
209387 |
002 |
NDA |
SODIUM NITROPRUSSIDE |
SOLUTION;INTRAVENOUS |
10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2017/03/08
|
2017/12/07
|
EXELA PHARMA |
Discontinued |
| NIPRIDE RTU IN SODIUM CHLORIDE 0.9% |
209387 |
003 |
NDA |
SODIUM NITROPRUSSIDE |
SOLUTION;INTRAVENOUS |
20MG/100ML (0.2MG/ML) |
Yes
|
Yes
|
2017/03/08
|
2018/07/13
|
EXELA PHARMA |
Prescription |